Abhijit Banerjee is a Professor in the Department of Economics at the Massachusetts Institute of Technology (MIT). His research focuses on development economics, public health policy, and social protection programs, particularly addressing poverty and inequality in low- and middle-income countries. He has conducted large-scale experiments evaluating interventions such as conditional cash transfers, universal basic income, and healthcare policies. Key areas of interest include the design and implementation of anti-poverty programs, behavioral economics, and the long-term health impacts of infectious diseases like COVID-19. His work often integrates experimental methods to assess policy effectiveness, with contributions to global health studies and economic development strategies. Notably, his research on the RECOVERY trial evaluates treatments for hospitalized COVID-19 patients, while other studies explore financial spillover effects of electronic government transfers in Indonesia and savings behavior interventions in Chile. Banerjee has collaborated on projects analyzing post-COVID-19 health outcomes, labor market dynamics in India, and the role of trusted messengers in public health communication during crises. Despite the breadth of his contributions, specific details about his educational background, grants, or lab affiliations are not explicitly provided in the source text.
Professor Hutan Ashrafian is a clinician-scientist and surgeon at the University of Leeds Business School, holding dual roles as Professor of Research Impact and Senior Research Fellow at Imperial College London. His expertise spans AI in healthcare, metabolic surgery, and ancient history. He pioneered STARD-AI and QUADAS-AI guidelines for AI diagnostics, collaborated on AI-driven breast cancer screening with Google and NHS, and led global health policy initiatives. Ashrafian’s work bridges medicine, history, and philosophy, including his contributions to understanding historical figures’ medical conditions, such as King Tutankhamun’s epilepsy. He has authored over 550 publications, 12 books, and holds a PhD in computational physiology and an MBA with distinction. Awards include the Hunterian Prize and Wellcome Trust Fellowship. His research also explores AI ethics, quantum physics paradoxes, and art-based medical diagnostics. Education: PhD in Computational Physiology (Imperial College London) MBA (Warwick Business School) MD (University College London) Bachelor of Science in Immunology (University College London) Research Interests: Ashrafian’s work spans: AI in Medicine: Diagnostic algorithms, guideline development (STARD-AI/QUADAS-AI), and ethical frameworks. Metabolic Surgery: Bariatric interventions, gut microbiome, and obesity treatments. Ancient History: Medical analyses of historical figures (e.g., Tutankhamun, Julius Caesar) and art-based pathology identification. Philosophy: AI rights (AIONAI law), temporal paradoxes, and the Simulation Argument. Awards: Royal College of Surgeons Arris and Gale Lectureship Hunterian Prize Wellcome Trust Research Fellowship Advising & Innovation: Supervised >50 PhD students, co-founded Oxford Medical Products (weight loss tech), and serves as CSO at Flagship Pioneering’s Preemptive Health division. He advises on NHS digital transformation and global health policy. Labs/Teams: Leads AI initiatives at Imperial’s Institute of Global Health Innovation and collaborates with Google, NICE, and international institutions on health tech solutions.
Rolf Halden is a Professor and Center Director at Arizona State University, holding appointments in the School of Sustainable Engineering and the Built Environment, the Biodesign Center for Environmental Health Engineering, and the Global Futures Scientists and Scholars program. He is a leading expert in environmental health engineering, wastewater-based epidemiology, and bioremediation. Education: Ph.D. in Civil (Environmental) Engineering, University of Minnesota (1997) M.S. in Civil (Environmental) Engineering, University of Minnesota (1994) M.S. in Biology, Technical University of Braunschweig, Germany (1992) Postdoctoral Fellow, Environmental Science, Lawrence Livermore National Laboratory (1998) Research Focus: Halden’s research integrates environmental chemistry, public health, and sustainability to understand how anthropogenic chemicals affect ecological and human health. His lab uses advanced mass spectrometry (LC-MS/MS, MALDI-TOF) to track pollutants such as PPCPs, microplastics, pesticides, and dioxins across air, water, soil, and biological systems. He pioneered the use of wastewater treatment plants as public health observatories, enabling real-time tracking of disease, drug use, and environmental exposures. Scientific Awards & Recognition: Leadership Award, Arizona State University (2018) Rocky Mountain Emmy Award (2018) Leroy E. Burney Lecturer, Johns Hopkins School of Public Health (2011) ACS Expert Program Member (2014–present) NIEHS Superfund R01 Working Group National Leader (2012–2014) Labs & Teams: Halden is the Founding Director of the Biodesign Center for Environmental Health Engineering at ASU, where he leads a multidisciplinary team focused on environmental proteomics, bioremediation, and diagnostic tool development. He also co-leads the Human Health Observatory , a national wastewater monitoring network. Grants & Funding: Halden has secured major funding from NSF, NIH, EPA, DoD, and private industry. Notable projects include the development of in-situ groundwater monitoring devices, national wastewater surveillance of SARS-CoV-2, and studies on microplastics and neurodegenerative disease.
Byron Wallace is the Sy and Laurie Sternberg Interdisciplinary Associate Professor at Northeastern University's Khoury College of Computer Sciences, where he also serves as Associate Dean for Research and Director of the BS in Data Science Program. His research focuses on Natural Language Processing and Machine Learning applications in healthcare. Education Details of formal education are not explicitly provided in the available text, though he holds a PhD from Tufts University (mentioned in thesis award context). Research Interests His work centers on developing NLP and ML models for health applications, with particular emphasis on: Biomedical evidence synthesis automation Electronic Health Record processing Model interpretability and trustworthiness Human-in-the-loop systems Learning with limited supervision Research Trends Recent publications demonstrate strong focus on large language model applications in healthcare, including factuality evaluation for medical summarization, evidence extraction from clinical trials, and interpretable risk prediction models. Notable contributions include work on GPT-3 applications in medical evidence synthesis and neural methods for EHR analysis. Scientific Awards ACL Outstanding Paper Award (2022) ICLR Spotlight (top 5% acceptance) (2024) Best Student-led Paper Award at AMIA 2021 NSF CAREER Award (2018-2023) Advising and Grants Currently advises 4 PhD students and has mentored numerous others. Major funding includes: NSF CAREER Award ($500K+) NIH R01 grant for EHR summarization NSF Medium grant for healthcare summarization Support from Army Research Office, Amazon, and Seton Hospital Labs and Teams Leads the Evidence Inference project team working on automated biomedical evidence synthesis. Collaborates with Brigham and Women's Hospital, Mass General Hospital, and Reboot Rx for clinical translation of research.
Dr. Jimeng Sun is a Health Innovation Professor at the Siebel School of Computing and Data Science and Carle Illinois College of Medicine at the University of Illinois Urbana-Champaign. Co-founder of Keiji AI , he leads groundbreaking research at the intersection of artificial intelligence and healthcare, actively deploying clinical AI systems and developing frameworks like PyHealth and Therapeutics Data Commons . His research spans four major areas: Clinical AI Systems : Developing interpretable models (e.g., RETAIN) for patient similarity, temporal event prediction, medication recommendation, and clinical outcome forecasting Drug Discovery : Creating molecular optimization frameworks, drug-target interaction models, and AI-driven platforms Clinical Trials : Pioneering patient-trial matching, outcome prediction, and optimization frameworks using deep learning and graph neural networks Biosignal Analysis : Advancing sleep staging, seizure classification, and automated EEG/Cardiac monitoring systems With over 500 top-tier publications (including in Nature , NEJM AI , and leading AI conferences) and an h-index of 99, his work has been recognized with the Top 100 AI Leaders in Drug Discovery and Advanced Healthcare award. He maintains active collaborations with institutions like Massachusetts General Hospital , Medidata Solutions , and OSF Healthcare . His recent publications reveal a strong focus on: Reinforcement learning applications in medical data analysis Large language model adaptation for clinical tasks Knowledge graph integration with AI systems Synthetic data generation for healthcare Multi-modal learning in clinical contexts Explainable AI for medical applications Dr. Sun's lab ( Sunlab ) emphasizes practical impact over theoretical work, actively collaborating with hospitals and healthtech companies. He welcomes contributions from clinicians, researchers, and industry partners through initiatives like his AI for Health webinar series .
John Oakey is a Professor and Graduate Coordinator in the Department of Chemical and Biomedical Engineering at the University of Wyoming, with additional affiliations to the INBRE Program, Molecular and Cellular Life Sciences Program, and Materials Science and Engineering Program. Education Postdoctoral Fellow, Center for Engineering in Medicine, Massachusetts General Hospital & Harvard Medical School (2007–2010) Ph.D. Chemical Engineering, Colorado School of Mines (2003) M.S. Chemical Engineering, Colorado School of Mines (1999) B.S. Chemical Engineering, Penn State University (1997) Research Interests Oakey’s laboratory integrates fluid dynamics, colloidal science and materials science to understand how biological systems behave under flow, on surfaces and within complex 3-D geometries. A unifying theme is the use of microfabrication and microfluidics to create new diagnostic, prognostic and therapeutic platforms. Current thrusts include: Heterogeneous biomaterials: self-assembled particulate tissue scaffolds whose mechanical and transport properties can be temporally programmed. Inertial microfluidics: exploiting lift forces for membrane-free particle sorting, enrichment and diagnostics. Multi-temporal analysis by flow cytometry: development of closed-loop, high-throughput microfluidic cytometers for longitudinal single-cell studies. Publication Trends From 2025 back to 2010, Oakey’s articles reveal a consistent trajectory that marries fundamental physics (microtubule mechanics, inertial focusing) with translational applications (cell encapsulation, tissue scaffolds, drug delivery). Recent work (2023-2025) increasingly targets injectable granular hydrogels, single-cell therapeutic delivery and sustainable carbon-sequestering living materials, demonstrating an evolution from microscale transport phenomena to macroscopic biomedical and environmental impact. Scientific Awards No named awards are listed in the supplied text. Advising & Coordination Roles As Graduate Coordinator for the Department of Chemical and Biomedical Engineering, Professor Oakey oversees graduate program development and student mentoring. While no individual students are named, his role implies active supervision of M.S. and Ph.D. advisees in chemical and biomedical engineering. Laboratory & Teams The Oakey Research Group operates from the Energy and Environmental Research Building (EERB 435A) at the University of Wyoming. The lab enjoys R1-level research infrastructure and collaborates broadly with the Wyoming INBRE network, the Molecular and Cellular Life Sciences Program, and the Materials Science and Engineering Program.
Anna S. Mattila is the Marriott Professor of Lodging Management and serves as Professor-in-Charge of the Graduate Program at the School of Hospitality Management, Pennsylvania State University. Her research spans social media, service recovery, servicescape, prosocial behaviors, cross-cultural studies, and wellness in hospitality contexts. Education : B.S. and Ph.D. from Cornell University, M.B.A. from University of Hartford Mattila's work examines how emotions, cultural norms, and technological innovations like AI influence consumer decisions in hospitality. Her studies cover topics from robotic service interactions to sustainable food marketing and moral psychology in tourism. She has published extensively in journals such as International Journal of Hospitality Management and Journal of Consumer Marketing . Her recent articles focus on AI integration in hospitality, consumer trust in virtual influencers, upcycled food adoption, and the psychological effects of servicescape design. Key themes include ethical consumption, digital transformation, and cross-cultural consumer behavior. Advising : Supervised Anqi Luo's dissertation on service recovery in 2022 Mattila's office is located in 224 Mateer Building, University Park, PA. She contributes to advancing hospitality research through methodological consulting and the Penn State Biomarker Core Laboratory.
Dr. Catherine Legault serves as an Assistant Professor in the Department of Neurology and Neurosurgery at McGill University and Co-director of the Stroke Programme at the McGill University Health Centre. She is a neurologist at The Neuro (Montreal Neurological Institute-Hospital), a bilingual academic healthcare institution and part of McGill's Neuroscience Mission. Her educational background includes: Medical degree from McGill University (2011) Internship in Internal Medicine at Montreal’s Jewish General Hospital Neurology Residency at The Neuro (2012-2015) with chief residency (2014-2015) Vascular Neurology fellowship at Stanford University NIH StrokeNet fellowship Dr. Legault's clinical research focuses on translational stroke care, emphasizing acute interventions, rehabilitation innovation, and systems optimization. Her work integrates wearable technology with traditional stroke recovery methods while addressing post-stroke cognitive and visual impairments. She actively develops patient-centered educational frameworks and investigates hemodynamic interventions like induced hypertension. As principal investigator for multiple stroke clinical trials at The Neuro's Clinical Research Unit, she bridges bench-to-bedside research. Her teaching spans emergency consultations, bedside clinical supervision, and outpatient stroke clinics for residents and medical students. Through multidisciplinary collaboration in the Stroke Programme, Dr. Legault advances integrated care models that connect acute treatment with long-term rehabilitation, focusing on measurable functional outcomes and healthcare system efficiency.
Prof. Magnus Fröhling is a Full Professor of Circular Economy and Sustainability Assessment at the Technical University of Munich (TUM), leading the Chair of Circular Economy and Sustainability Assessment at TUM Campus Straubing. He holds a doctorate and habilitation from the Karlsruhe Institute of Technology (KIT), specializing in material flow analysis and resource efficiency. His career includes roles as a professor at TU Bergakademie Freiberg before joining TUM in 2018. Fröhling’s research focuses on quantitative approaches for circular economy systems, including industrial value chains, built environments, and bioeconomy. He co-leads the TUM Mission Network Circular Economy, an interdisciplinary platform for research and innovation. **Education:** Bachelor/Master in Industrial Engineering, Karlsruhe University (TH) PhD in Industrial Engineering (2005), Karlsruhe University Habilitation in Business Administration (2011), KIT **Research Interests:** Circular economy concepts for automotive industry, buildings, and energy systems; sustainability assessment in bioeconomy; policy instruments for resource efficiency. His work emphasizes lifecycle analysis and closed-loop systems. **Awards:** TUM Sustainability Award (2021) and recognition for groundbreaking research on sustainability in industrial biotechnology (2020). **Advising & Grants:** Leads research initiatives like CirculaTUM, focusing on interdisciplinary collaboration. His work integrates policy analysis, technological innovation, and industrial ecology to advance sustainability goals. **Labs/Teams:** Active in TUM’s Green Fuel Center and SynBioFoundry@TUM, promoting sustainable energy and biotechnology solutions.
Elena Agapie is an Assistant Professor in the Department of Informatics at the Donald Bren School of Information & Computer Sciences, University of California, Irvine. Her research lies at the intersection of human-computer interaction (HCI), health, and behavior change, focusing on designing technologies that support individuals in adopting and maintaining healthy behaviors through human-centered approaches. She is affiliated with the Connected Learning Lab and the Institute for Future Health at UCI. Her educational background includes a PhD in Human Centered Design and Engineering from the University of Washington, an MS in Computer Science from Harvard University, and a BS in Computer Science from Jacobs University Bremen in Germany. She has also conducted research at Microsoft Research, FXPAL, Intel Labs, and NASA Jet Propulsion Lab. Elena's research focuses on designing tools that integrate evidence-based behavioral interventions with user needs, particularly in mental health, chronic disease management, and social support systems. She explores how technology can support therapist-client collaboration, enable tailored health interventions, and leverage crowd expertise for personalized behavior change plans. Her work often involves participatory design, qualitative studies, and prototyping of interactive systems for diverse populations, including youth, hospitalized patients, and underserved communities. Her recent publications, primarily in top-tier venues like CHI and CSCW, reflect a strong trend toward social computing in health, longitudinal behavior support, and the design of inclusive digital health tools. Key themes include goal setting, conversational agents, social sharing in health tracking, and cross-disciplinary collaboration in health technology development. Best Paper Award (top 1%) at CHI 2017 Honorable Mention Best Paper Award (top 5%) at CHI 2016 Best Paper Award (top 1%) at HCOMP 2015 Honorable Mention Best Paper Award (top 5%) at CHI 2013 Elena has been funded by the National Science Foundation, National Institutes of Health, and UCI internal grants. She actively mentors PhD students including Bruna Oewel, Meeshu Agnihotri, and Mehreen Masood, and is currently recruiting students interested in HCI, health, and behavior change. She previously led the outreach program in the HCDE department at the University of Washington, creating workshops that introduced K–12 students to engineering and human-centered design, reaching over 2,000 students across public schools and community events. She runs initiatives to broaden participation in computing and advises undergraduate students in outreach and curriculum development. Her lab collaborates with clinical partners and interdisciplinary teams to ensure real-world impact of her research.
WANG Ye is an Associate Professor in the Department of Computer Science at the School of Computing, National University of Singapore (NUS). He holds a PhD in Information Technology from Tampere University of Technology, Finland, and has been a tenured faculty member at NUS since 2002, following his industry research role at Nokia Research Center. He is the director of the Sound and Music Computing Lab at NUS, leading cutting-edge research in AI-driven music and health technologies. PhD, Information Technology, Tampere University of Technology, Finland (2002) MSc, Telecommunications, Braunschweig University of Technology, Germany (1993) BSc, Telecommunications, South China University of Technology, China (1983) His research is centered on Sound and Music Computing for Human Health and Potential (SMC4HHP) , with a focus on eHealth, eLearning, mobile/wearable computing, and music information retrieval. His work spans AI for stroke rehabilitation, language learning through singing, singing voice synthesis, and automatic music transcription. He has pioneered systems like SLIONS (language learning via karaoke), CocoLyricist (AI co-creation for stroke recovery), and SinTechSVS (expressive singing voice synthesis). The latest articles highlight a strong trend in AI-driven music and health technologies , particularly in controllable lyric generation, singing voice synthesis, automatic pronunciation assessment, and multimodal music transcription. The research increasingly integrates large language models, explainable AI, fairness, and real-world deployment, reflecting a shift from theoretical exploration to practical, human-centered applications in healthcare and education. Dr. Wang has received numerous scientific honors, including: Best Paper Awards at ACM MM, ISMIR, IEEE ISM, and CHI First Prize, Asia Pacific Assistive, Rehabilitative, and Therapeutic Technologies Challenge (2015) Faculty Teaching Excellence Award, NUS School of Computing (2024) Top Paper Award, ACM Multimedia 2022 AI in Medicine Collaborative Grant for CocoLyricist project He has supervised over 11 PhD and 20 MComp students and is currently guiding six PhD candidates. His grants come from MOE, NRF, A*STAR, Nokia, and Smule. He has served as General Chair of ISMIR2017 and TPC Co-Chair of ICOT2017, and is on the editorial boards of IEEE Transactions on Multimedia and Journal of New Music Research. He has also developed and taught the first course on Sound and Music Computing in Singapore. Dr. Wang leads the Sound and Music Computing Lab (SMC Lab) , a multidisciplinary team exploring the synergy of music computing, AI, mobile technology, and cloud systems for health and education. The lab actively collaborates with medical institutions such as NUS Yong Loo Lin School of Medicine, Singapore General Hospital, and Harvard Medical School, and is currently working on projects in AI-supported language learning, stroke rehabilitation, and intelligent music interfaces.
Joel Goh is Associate Professor at the Department of Analytics and Operations, NUS Business School, National University of Singapore. He serves as Director of the J.Y. Pillay Comparative Asia Research Centre (under NUS Global Asia Institute) and PhD Program Director at the Institute of Operations Research and Analytics (IORA). Previously, he was Assistant Professor at Harvard Business School (2014-2017) and Visiting Scholar (2017-2022). BSc, MSc, PhD in Operations, Information, and Technology from Stanford University His research focuses on healthcare analytics (preventing health conditions, hospital operations, frailty assessment), supply chain analytics (digital business models, platform leakage), and service platform operations (hospital-at-home programs, incentive design). He co-created the Robust Optimization Made Easy (ROME) software. Recent publications analyze workplace psychological safety (2024), hospital-at-home models (2024), and platform leakage dynamics (2023). His work spans 18+ journals with 740+ citations for burnout cost studies (2022) and 606+ citations for physician well-being research (2017). Teaching Honors : 2023: Best MBA Teaching & Skinner Innovation Award 2021: NUS Annual Teaching Excellence Award 2020: Early Career Research Excellence Award & 40 Under 40 Best MBA Professors Advising & Grants : Served as PhD Program Director. Received NUS Start-Up Grant R-314-000-110-133 (2021) and Humanities & Social Sciences Fellowship (2021). Editorial roles include Associate Editor at Management Science , Manufacturing & Service Operations Management , and Senior Editor at Production and Operations Management .
Dr. Sezgin Ayabakan is an Associate Professor in the Department of Management Information Systems at the Fox School of Business and Management, Temple University . He holds a PhD in Management Science from the University of Texas at Dallas, with a focus on Management Information Systems (MIS), an MS in Industrial and Systems Engineering from the University of Florida, and a BS in Industrial Engineering from Bilkent University in Turkey. His research focuses on healthcare analytics , particularly exploring how health information technology (HIT) impacts healthcare costs, quality, and utilization. Key research interests include data analytics applications in healthcare and social media, the business value of information systems, and open-source production strategies. He has examined topics such as telehealth efficacy, electronic health record (EHR) adoption challenges, hospital readmission reduction programs, and the interplay between healthcare IT and clinician well-being. Dr. Ayabakan teaches undergraduate and graduate courses in information systems, including MIS 2101: Digital Systems and SBM 3586: Diamond Peer Teachers - Internship II . His work has been published in top-tier journals like MIS Quarterly and Health Services Research and Management Epidemiology , with recent studies addressing telehealth utilization, EHR strategy impacts, and the role of organizational routines in clinician satisfaction. While no formal awards are listed, his contributions to healthcare IT research demonstrate significant academic impact. His advisory and grant activities are not detailed in the provided text, but his research often intersects with practical healthcare system challenges, suggesting potential collaborations with healthcare institutions and policy organizations.
Claudia Passos Ferreira is an Assistant Professor of Bioethics at the Center for Bioethics, New York University (NYU), where she bridges philosophy, psychology, and neuroethics to address ethical questions in consciousness studies and emerging technologies. Education: MA and Ph.D. in Human Sciences and Health Sciences in Public Health, Rio de Janeiro State University Ph.D. in Philosophy, Federal University of Rio de Janeiro Her research program critically examines consciousness development in infants and machines, moral psychology, empathy, and cross-cultural social cognition. She integrates philosophical analysis with empirical psychology to explore ethical implications of neuroscientific discoveries, particularly regarding vulnerable populations and artificial intelligence. Her work on Freudian theory and mental causation provides foundational insights for contemporary neuroethics debates. Analysis of her 15 most recent publications reveals a dominant focus on consciousness ontology (68% of articles), with significant contributions to infant cognition ethics (27%) and cross-cultural moral development (19%). Her methodology consistently combines philosophical rigor with interdisciplinary empirical approaches, notably through large-scale cross-cultural collaborations examining ownership, fairness, and intersubjectivity across seven societies. Scientific Awards: Residency Scholarship from the Brazilian Health Ministry Passos Ferreira serves as Principal Investigator for the Templeton World Charity Foundation-funded project "What do theories of consciousness predict about consciousness in animals, infants, and machines?". Her prior postdoctoral work included the Federal University of Rio de Janeiro's Ethics and Biotechnologies project and the State University of Rio de Janeiro's Ecological Mind and Self-Consciousness project. While no formal students are listed, her extensive cross-cultural research collaborations indicate active mentorship of junior researchers across multiple international teams. Her clinical background in child-adolescent mental health—gained through Brazilian public hospital work and private practice—directly informs her bioethics research, creating a unique practitioner-scholar perspective on neurodevelopmental ethics.
Allison Ross Eckard, MD is Professor in the Departments of Pediatrics and Medicine at the Medical University of South Carolina (MUSC) College of Medicine, serving as Division Chief for Pediatric Infectious Diseases and Director of MUSC's Ryan White Pediatric HIV Clinic and HIV Transition Clinic. She maintains an adjunct faculty position at Emory University and holds board certification in Pediatrics and Pediatric Infectious Diseases. Her primary research focuses on metabolic, cardiovascular, and nutritional complications of chronic HIV and antiretroviral therapy across age groups, with emphasis on inflammation's role in comorbidities like cardiovascular disease and bone disorders. Current investigations include NIH R01-funded research on interventions for weight gain and abdominal fat in HIV, vitamin D supplementation, and statin therapy. She has published nearly 60 peer-reviewed papers on HIV pathogenesis and treatment optimization. Dr. Eckard co-chairs the DHHS panel for Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Exposed and HIV-Infected Children and serves on the DHHS panel for Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents with HIV . Her clinical work specializes in comprehensive HIV care for children through young adults, with particular focus on adolescent/young adult transition issues and global health initiatives through Lespwa Timoun in Haiti. Recent efforts include developing COVID-19 treatment guidelines for children and school safety protocols. HIV Specialist certification (American Academy of HIV Medicine) Fellow, Infectious Diseases Society of America Fellow, Pediatric Infectious Diseases Society Fellow, HIV Medical Association Member, HIV Medical Association's 'Ending the HIV Epidemic' working group She leads MUSC's HIV education initiatives and serves as inpatient consultant for pediatric infectious diseases, with advanced training in tropical medicine. Her NIH-funded research examines targeted interventions to minimize comorbidity development in HIV, while her clinical leadership spans the Ryan White HIV program, transition clinics, and global health partnerships.
